Finance

Lists
Why is XBIT up 4,17%?
Dive Deeper
XBIT:NASDAQ
XBiotech Inc
1,75 US$
+4,17%
(+0,070) 1D
20 ნოე, 11:47:59 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XBIT...
Open
1,68 US$
High
1,78 US$
Low
1,61 US$
Mkt. cap
53,35 მლნ.
Avg. vol.
84,09 ათ.
Volume
48,71 ათ.
52-wk high
2,73 US$
52-wk low
1,61 US$
EPS
-1,43 US$
Beta
0,76
Shares outstanding
30,49 მლნ.
No. of employees
52
Open
1,68 US$
High
1,78 US$
Low
1,61 US$
Mkt. cap
53,35 მლნ.
Avg. vol.
84,09 ათ.
Volume
48,71 ათ.
52-wk high
2,73 US$
52-wk low
1,61 US$
EPS
-1,43 US$
Beta
0,76
Shares outstanding
30,49 მლნ.
No. of employees
52
News stories
From web sources and news partners
Profile
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
About XBiotech Inc
CEO-
Employees52
Founded2005
Headquartersოსტინი, ტეხასი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
25,36 მლნ.
5,21 მლნ.
5,30 მლნ.
4,66 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,40 მლნ.
1,07 მლნ.
850,00 ათ.
663,00 ათ.
Operating expense
29,76 მლნ.
6,27 მლნ.
6,15 მლნ.
5,32 მლნ.
Total operating expenses
29,76 მლნ.
6,27 მლნ.
6,15 მლნ.
5,32 მლნ.
Operating income
-29,76 მლნ.
-6,27 მლნ.
-6,15 მლნ.
-5,32 მლნ.
Other non operating income
-8,00 ათ.
1,04 მლნ.
-9,00 ათ.
15,00 ათ.
EBT including unusual items
-26,82 მლნ.
-5,46 მლნ.
-6,68 მლნ.
-4,42 მლნ.
EBT excluding unusual items
-27,37 მლნ.
-5,46 მლნ.
-6,68 მლნ.
-4,42 მლნ.
Income tax expense
76,00 ათ.
49,00 ათ.
46,00 ათ.
35,00 ათ.
Effective tax rate
-0,28%
-0,90%
-0,69%
-0,79%
Other operating expenses
-
-
-
-
Net income
-26,89 მლნ.
-5,50 მლნ.
-6,73 მლნ.
-4,46 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1,22 მლნ.
914,00 ათ.
885,00 ათ.
831,00 ათ.
Interest expense
-
-
-
-
Net interest expenses
1,22 მლნ.
914,00 ათ.
885,00 ათ.
831,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-29,38 მლნ.
-5,94 მლნ.
-5,84 მლნ.
-5,07 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები